Polymer Capital Management (HK) LTD
Position in NRIX — Nurix Therapeutics, Inc.
CIK 1970465
HONG KONG, K3
Position in NRIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,428,865
+$515,946 QoQ
Shares Held
58,898
0.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#98
of 210 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polymer Capital Management (HK) LTD holds $79,733,655 across 15 Biotechnology names. NRIX ranks #12 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
64,957 | $19,554,005 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
177,897 | $14,105,453 | |
| 3 | CYTK |
Cytokinetics Inc
|
138,255 | $11,777,943 | |
| 4 | ERAS |
Erasca, Inc.
|
478,020 | $8,757,326 | |
| 5 | LEGN |
Legend Biotech Corp
|
165,209 | $4,771,235 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
263,662 | $3,939,110 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
224,853 | $3,276,108 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
36,800 | $2,999,568 |
All Filings in NRIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,428,865 | 58,898 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $912,919 | 58,898 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,117,295 | 58,898 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $544,217 | 58,898 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $670,848 | 58,898 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $699,708 | 58,898 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $943,846 | 50,098 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||